Hi, 欢迎访问门门
登录 | 注册
IOS
Android
- 抗VEGFR2/ KDR/ CD309相关抗体(AT001)
- Procollagen type I C-terminal propeptide(human， PICP)
- D-Serine
- Aprotinin
- 抗ANGPT2相关抗体(zansecimab)
- 抗B7-H3/ CD276相关抗体(mirzotamAb)
- 抗IL-6Ra/ CD126相关抗体(APX007)
- 抗ICOS/ CD278相关抗体(feladilimab)
- 抗TNFSF13B/ BAFF/ CD257相关抗体(tabalumab)
- Complement component C1s(human， pro- and activated enzyme)
- 抗PAR2相关抗体(Regeneron patent抗PAR-2)
- 抗TNFSF4/ OX40L/ CD252相关抗体(oxelumab)
- 抗IL-7Ra/ CD127相关抗体(lusvertikimab)
- 抗ERBB1/ EGFR/ HER1相关抗体(Shanghai Cancer Inst patent抗EGFRvIII)
- 抗IL-2Ra/ CD25相关抗体(camidanlumAb)
- 抗BCMA& CD3相关抗体(pavurutamab)
- 抗CD123& CD3相关抗体(Flotetuzumab)
- 抗CD47相关抗体(magrolimab)
- 抗CD20& CD3相关抗体(Mosunetuzumab)
- 打牌(精)
- 数学-(2025)题源·十年真题分类
- 有道英语考研词汇
- 酸辣粉技术培训|酸辣粉做法培训|正宗酸辣粉培训
- 网络营销培训
- 综合布线工程培训
- Aripiprazole
- Perospirone Hydrochloride Dihydrate
- (+)-SCH23390 Hydrochloride
- Anti Human Podoplanin， Monoclonal Antibody
- Anti IDH1， Monoclonal Antibody
- 0.01mol/L Phosphate Buffered Saline
- Lemosol
- DAB Tablet(DAB·4HCl 5 mg/tablet)
- Amyloidβ-Protein Immunohistostain Kit
- 2-Cl-C.OXT-A
- Methylazoxymethanol Acetate
- W-5 Hydrochloride
- Suramin Sodium
- KN-93
- AM 630
- AM 281
- D-Serine
- (S)-5-Fluorowillardiine
- Evans Blue
- DL-a-(3，5-Dihydroxyphenyl) glycine
- D(-)-2-Amino-5-phosphonovaleric Acid
- (±)-Sulpiride
- Milnacipran Hydrochloride
- Sertraline Hydrochloride
- Amoxapine
- Humanβ Amyloid(1-42) ELISA Kit Wako
- Human/Ratβ Amyloid(42) ELISA Kit Wako， High Sensitive
- 抗CD3& FLT3相关抗体(emirodatamab)
- 抗CA125& CD3相关抗体(ubamatamab)
- 抗B7-H4& CD3相关抗体(GEN1047)
- 抗CD47& Mesothelin相关抗体(NI-1801)
- 抗CD3& HER2/neu相关抗体(M802)
- 抗BCMA& CD3相关抗体(EMB-06)
- 抗BCMA& CD3相关抗体(EMB-06)
- 抗A33& CD3相关抗体(MGD007)
- 抗CD3& PSMA相关抗体(Acapatamab)
- 抗CD3& CD38相关抗体(Y-150)
- 抗BCMA& CD3相关抗体(Linvoseltamab)
- 抗gp100& CD3相关抗体(Kimmtrak)
- 抗Her2& Her2相关抗体(Zanidatamab Zovodotin)
- 抗Her2& Her2相关抗体(Zanidatamab)
- 抗ROR1& CD3相关抗体(ROR1xCD3 DART)
- 抗TNFalpha& IL17相关抗体(ABT122)
- 抗Her2& Her3相关抗体(MM-111)
- 抗B7H3& CD3相关抗体(Obrindatamab)
- 抗CLL-1& CD3相关抗体(Tepoditamab)
- 抗CD19& CD3相关抗体(Duvortuxizumab(USAN))
- 抗CD19& CD3相关抗体(Duvortuxizumab(USAN))
- 抗EGFR& cMet相关抗体(Amivantamab)
- 抗CD38& CD3相关抗体(GBR1342)
- 抗CD38& CD3相关抗体(GBR1342)
- 抗CD19& CD3相关抗体(Blinatumomab)
- 抗CD33& CD3相关抗体(Eluvixtamab)
- 抗EpCAM& CD3相关抗体(M701)
- 抗C3& VEGF相关抗体(efdamrofusp alfa)
- 抗C3& VEGF相关抗体(efdamrofusp alfa)
- 抗BCMA& CD3相关抗体(pavurutamab)
- 抗CD3& EpCAM相关抗体(Catumaxomab(huIgG1-rat IgG2b))
- 抗CD3& EpCAM相关抗体(Catumaxomab(mIgG2a-rat IgG2b))
- 抗CD3& FCRL5相关抗体(Cevostamab)
- 抗CD3& FCRL5相关抗体(Cevostamab)
- 抗PD-1& CTLA-4相关抗体(Fidasimtamab)
- 抗CD73& TGF-β相关抗体(Dalutrafusp alfa)
- 抗CD3& DLL3相关抗体(Tarlatamab)
- 抗CD3& CD20相关抗体(Epcoritamab)
- 抗EGFR& Her3相关抗体(izalontamab)
- 抗CD30& CD16A相关抗体(AFM13)
- 抗ANG2& VEGFA相关抗体(Vanucizumab(USAN/INN))
- 抗CD20& CD3相关抗体(Mosunetuzumab)
- 抗LGR5& EGFR相关抗体(Petosemtamab)
- 抗LGR5& EGFR相关抗体(Petosemtamab)
- 抗CanAg相关抗体(Cantuzumab)
- 抗GPC2/ Glypican 2相关抗体(Nih Patent抗Glypican-2)
- 抗GPC2/ Glypican 2相关抗体(Nih Patent抗Glypican-2)
- 抗GPC2/ Glypican 2相关抗体(Nih Patent抗Glypican-2)